Univest Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.51M | Sell |
6,937
-223
| -3% | -$49.5K | 0.08% | 130 |
|
|
2025
Q4 | $1.64M | Sell |
7,160
-364
| -5% | -$82.9K | 0.09% | 132 |
|
|
2025
Q3 | $1.74M | Sell |
7,524
-228
| -3% | -$46.4K | 0.1% | 123 |
|
|
2025
Q2 | $1.44M | Buy |
7,752
+180
| +2% | +$33.5K | 0.09% | 130 |
|
|
2025
Q1 | $1.59M | Sell |
7,572
-340
| -4% | -$66.1K | 0.1% | 129 |
|
|
2024
Q4 | $1.41M | Sell |
7,912
-315
| -4% | -$57.9K | 0.09% | 135 |
|
|
2024
Q3 | $1.62M | Buy |
+8,227
| New | +$1.54M | 0.11% | 123 |
|
|
2023
Q4 | – | Sell |
-1,728
| Closed | -$258K | – | 119 |
|
|
2023
Q3 | $258K | Hold |
1,728
| – | – | 0.09% | 93 |
|
|
2023
Q2 | $233K | Hold |
1,728
| – | – | 0.07% | 105 |
|
|
2023
Q1 | $275K | Sell |
1,728
-34
| -2% | -$5.2K | 0.09% | 81 |
|
|
2022
Q4 | $285K | Sell |
1,762
-741
| -30% | -$114K | 0.09% | 87 |
|
|
2022
Q3 | $336K | Sell |
2,503
-898
| -26% | -$129K | 0.11% | 78 |
|
|
2022
Q2 | $521K | Sell |
3,401
-640
| -16% | -$97.8K | 0.17% | 63 |
|
|
2022
Q1 | $655K | Sell |
4,041
-36,847
| -90% | -$5.35M | 0.18% | 58 |
|
|
2021
Q4 | $5.54M | Sell |
40,888
-417
| -1% | -$49.3K | 1.41% | 24 |
|
|
2021
Q3 | $4.46M | Buy |
41,305
+662
| +2% | +$75.6K | 1.24% | 33 |
|
|
2021
Q2 | $4.58M | Sell |
40,643
-1,365
| -3% | -$154K | 1.26% | 33 |
|
|
2021
Q1 | $4.55M | Buy |
42,008
+117
| +0.3% | +$12.5K | 1.28% | 31 |
|
|
2020
Q4 | $4.49M | Buy |
41,891
+359
| +0.9% | +$34.5K | 1.3% | 32 |
|
|
2020
Q3 | $3.64M | Sell |
41,532
-838
| -2% | -$78.9K | 1.15% | 34 |
|
|
2020
Q2 | $4.16M | Sell |
42,370
-416
| -1% | -$36.6K | 1.37% | 26 |
|
|
2020
Q1 | $3.26M | Sell |
42,786
-22,700
| -35% | -$1.93M | 1.29% | 32 |
|
|
2019
Q4 | $4.1M | Buy |
65,486
+18,268
| +39% | +$1.52M | 1.74% | 8 |
|
|
2019
Q3 | $3.58M | Buy |
47,218
+429
| +0.9% | +$29.4K | 1.15% | 37 |
|
|
2019
Q2 | $3.4M | Buy |
46,789
+1,077
| +2% | +$84.7K | 1.08% | 40 |
|
|
2019
Q1 | $3.68M | Buy |
45,712
+3,110
| +7% | +$254K | 1.21% | 35 |
|
|
2018
Q4 | $3.93M | Buy |
42,602
+2,183
| +5% | +$192K | 1.45% | 20 |
|
|
2018
Q3 | $3.82M | Buy |
40,419
+401
| +1% | +$38K | 1.17% | 32 |
|
|
2018
Q2 | $3.71M | Buy |
40,018
+282
| +0.7% | +$27.5K | 1.49% | 31 |
|
|
2018
Q1 | $3.76M | Sell |
39,736
-9,480
| -19% | -$1.04M | 1.63% | 29 |
|
|
2017
Q4 | $4.76M | Sell |
49,216
-2,944
| -6% | -$277K | 1.92% | 18 |
|
|
2017
Q3 | $4.63M | Sell |
52,160
-6,576
| -11% | -$501K | 1.96% | 15 |
|
|
2017
Q2 | $4.26M | Buy |
58,736
+73
| +0.1% | +$4.91K | 1.79% | 17 |
|
|
2017
Q1 | $3.82M | Sell |
58,663
-6,823
| -10% | -$429K | 1.67% | 22 |
|
|
2016
Q4 | $4.1M | Sell |
65,486
-2,966
| -4% | -$181K | 1.74% | 8 |
|
|
2016
Q3 | $4.32M | Buy |
68,452
+243
| +0.4% | +$15.7K | 1.95% | 7 |
|
|
2016
Q2 | $4.22M | Sell |
68,209
-1,843
| -3% | -$112K | 1.93% | 4 |
|
|
2016
Q1 | $4M | Buy |
70,052
+5,390
| +8% | +$300K | 1.82% | 11 |
|
|
2015
Q4 | $3.83M | Buy |
64,662
+2,211
| +4% | +$127K | 1.75% | 17 |
|
|
2015
Q3 | $3.4M | Sell |
62,451
-3,343
| -5% | -$218K | 1.66% | 23 |
|
|
2015
Q2 | $4.42M | Sell |
65,794
-1,820
| -3% | -$119K | 2.03% | 7 |
|
|
2015
Q1 | $3.96M | Buy |
67,614
+2,505
| +4% | +$151K | 1.78% | 12 |
|
|
2014
Q4 | $4.26M | Buy |
65,109
+160
| +0.2% | +$10.1K | 1.87% | 10 |
|
|
2014
Q3 | $3.75M | Sell |
64,949
-3,581
| -5% | -$199K | 1.76% | 13 |
|
|
2014
Q2 | $3.87M | Buy |
68,530
+1,219
| +2% | +$64K | 1.82% | 12 |
|
|
2014
Q1 | $3.46M | Buy |
67,311
+2,761
| +4% | +$140K | 1.73% | 16 |
|
|
2013
Q4 | $3.41M | Buy |
64,550
+11,144
| +21% | +$548K | 1.68% | 19 |
|
|
2013
Q3 | $2.39M | Buy |
53,406
+5,543
| +12% | +$246K | 1.27% | 45 |
|
|
2013
Q2 | $1.98M | Buy |
+47,863
| New | +$2.09M | 1.08% | 50 |
|
Other funds holding ABBV
VCM
VPM
Univest Financial's ABBV Position: Q1 2026 in Review
Univest Financial reduced its AbbVie (ABBV) stake by 3.1% in Q1 2026, selling an estimated $49.5K and leaving 6,937 shares worth $1.51M. The position accounts for 0.08% of the portfolio, ranked #130.
Univest Financial first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $5.54M in Q4 2021. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Univest Financial held 6,937 shares of AbbVie worth $1.51M as of Q1 2026.
- Univest Financial sold 223 AbbVie shares in Q1 2026, an estimated $49.5K.
- AbbVie made up 0.08% of Univest Financial's portfolio in Q1 2026, its #130 holding.
- Univest Financial first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Univest Financial's AbbVie position peaked at $5.54M in Q4 2021.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Univest Financial's 13F filing for Q1 2026, filed 1 May 2026.